Skip to content

Point-of-care gastric ultrasound assessment of gastric residual volume in fasted breast cancer patients undergoing neoadjuvant chemotherapy prior to elective surgery: a prospective observational study

Point-of-care gastric ultrasound assessment of gastric residual volume in fasted breast cancer patients undergoing neoadjuvant chemotherapy prior to elective surgery: a prospective observational study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098662
Enrollment
Unknown
Registered
2025-03-12
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Sponsors

Jiangsu Province Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for the Chemotherapy Group: 1. Age: 20-65 years old; 2. BMI < 40 kg/m² ; 3. Histologically or cytologically confirmed breast cancer; 4. Received at least four cycles of neoadjuvant chemotherapy before surgery and planned for elective surgery; Inclusion Criteria for the Non-Chemotherapy Group: 1. Age: 20-65 years old; 2. BMI < 40 kg/m² ; 3. Diagnosed with breast nodules or masses by imaging;

Exclusion criteria

Exclusion criteria: Exclusion Criteria for the Chemotherapy Group: 1. History of subtotal gastrectomy; 2. Current gastrointestinal obstruction or hiatal hernia; 3. Diabetes mellitus; 4. Pregnant women; 5. Inability to cooperate with the gastric ultrasound procedure; 6. Severe dysfunction of important organs such as heart, lung, liver, or kidney; Exclusion Criteria for the Non-Chemotherapy Group: 1. History of subtotal gastrectomy; 2. Current gastrointestinal obstruction or hiatal hernia; 3. Diabetes mellitus; 4. Pregnant women; 5. Inability to cooperate with the gastric ultrasound procedure; 6. Severe dysfunction of important organs such as heart, lung, liver, or kidney; 7. Patients who received neoadjuvant chemotherapy before surgery.

Design outcomes

Primary

MeasureTime frame
the incidence of delayed gastric empty;

Countries

China

Contacts

Public ContactHe Jianhua

Jiangsu Province Cancer Hospital

Hejianhua_73@163.com+86 137 7070 1804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026